<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Layden RM</submitter><funding>National Institute of Neurological Disorders and Stroke/National Institute on Aging</funding><funding>NINDS NIH HHS</funding><pagination>e71032</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12836376</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(1)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>This studyexamined the independent contribution of chronic traumatic encephalopathy (CTE) neuropathology to symptoms.&lt;h4>Methods&lt;/h4>The sample included 614 brain donors with (n = 366) and without (n = 248) autopsy-confirmed CTE. Brain donors with other major neurodegenerative disease diagnoses were excluded. Informants completed cognitive and neuropsychiatric measures. Dementia was determined during diagnostic consensus conferences.&lt;h4>Results&lt;/h4>CTE stage IV (of IV) was associated with 4.48 (95% confidence interval [CI] = 1.97-10.90) increased odds of having dementia. CTE stage III had an odds ratio of 2.12 (95% CI = 1.91-3.77). Higher CTE stage was associated with greater informant-reported cognitive symptoms (p &lt; 0.01). There were no associations with mood/behavio</pubmed_abstract><journal>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</journal><pubmed_title>CTE neuropathology alone is associated with dementia and cognitive symptoms.</pubmed_title><pmcid>PMC12836376</pmcid><funding_grant_id>R01NS122854</funding_grant_id><funding_grant_id>R01NS139383</funding_grant_id><funding_grant_id>U54 NS115266</funding_grant_id><pubmed_authors>Mez J</pubmed_authors><pubmed_authors>Nowinski CJ</pubmed_authors><pubmed_authors>Goldstein LE</pubmed_authors><pubmed_authors>Miner AE</pubmed_authors><pubmed_authors>Palmisano JN</pubmed_authors><pubmed_authors>Layden RM</pubmed_authors><pubmed_authors>Stern RA</pubmed_authors><pubmed_authors>Groh JR</pubmed_authors><pubmed_authors>Martin BM</pubmed_authors><pubmed_authors>Gil SG</pubmed_authors><pubmed_authors>Kidd A</pubmed_authors><pubmed_authors>Stein TD</pubmed_authors><pubmed_authors>McKee AC</pubmed_authors><pubmed_authors>Alosco ML</pubmed_authors><pubmed_authors>Cantu RC</pubmed_authors><pubmed_authors>Tripodis Y</pubmed_authors><pubmed_authors>Nosek SB</pubmed_authors><pubmed_authors>Daneshvar DH</pubmed_authors><pubmed_authors>Lenio S</pubmed_authors><pubmed_authors>Abdolmohammadi B</pubmed_authors><pubmed_authors>Dwyer BC</pubmed_authors><pubmed_authors>Katz DI</pubmed_authors></additional><is_claimable>false</is_claimable><name>CTE neuropathology alone is associated with dementia and cognitive symptoms.</name><description>&lt;h4>Introduction&lt;/h4>This studyexamined the independent contribution of chronic traumatic encephalopathy (CTE) neuropathology to symptoms.&lt;h4>Methods&lt;/h4>The sample included 614 brain donors with (n = 366) and without (n = 248) autopsy-confirmed CTE. Brain donors with other major neurodegenerative disease diagnoses were excluded. Informants completed cognitive and neuropsychiatric measures. Dementia was determined during diagnostic consensus conferences.&lt;h4>Results&lt;/h4>CTE stage IV (of IV) was associated with 4.48 (95% confidence interval [CI] = 1.97-10.90) increased odds of having dementia. CTE stage III had an odds ratio of 2.12 (95% CI = 1.91-3.77). Higher CTE stage was associated with greater informant-reported cognitive symptoms (p &lt; 0.01). There were no associations with mood/behavio</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-09T06:52:29.838Z</modification><creation>2026-06-09T03:12:06.328Z</creation></dates><accession>S-EPMC12836376</accession><cross_references><pubmed>41589584</pubmed><doi>10.1002/alz.71032</doi></cross_references></HashMap>